Valmet to Retrofit the Automation System at Alholmens Kraft's Biopower Plant in Pietarsaari, Finland

Valmet will replace an existing third-party automation system with a Valmet DNA Automation System at Oy Alholmens Kraft Ab’s power plant unit AK1 in Pietarsaari, Finland. The delivery will be handed over to the customer in November 2023.

The order was included in Valmet’s orders received of the fourth quarter 2022. The value of the order will not be disclosed. 

“Our other power plant unit AK2, which is one of the world’s largest biomass-fired combined heat and power (CHP) plants, has been run reliably with the Valmet DNA since its startup in 2001. Now we want to have the same system for our AK1 unit, too. After the retrofit, we will have only one automation system throughout the entire plant,” says Johannes Östman, Automation Engineer, Oy Alholmens Kraft Ab.

“Having only one automation system makes support and future updates easier for the customer. Valmet has extensive experience and knowhow in replacing other suppliers’ automation systems,” says Tom Bäckman, Sales Manager, Automation Systems business line, Valmet.

Close cooperation between Alholmens Kraft and Valmet goes back for decades. One of the latest projects includes a Valmet DNA turbine automation retrofit on AK2 in 2022.

Information about the delivery

Valmet’s delivery scope will cover a Valmet DNA Automation System, including system hardware and software as well as installation and commissioning.

Information about the customer Alholmens Kraft

The Alholmens Kraft biopower plant is located on the site of the UPM Pietarsaari mill in Pietarsaari, Western Finland. The power plant unit AK1 was completed in 1986 and has an electrical capacity of 35 MW and a thermal capacity of 150 MW. It runs on wood-based fuels.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.